Valutazione del danno epatico nel paziente nefropatico con infezione da HCV: quali sono le caratteristiche e i rischi dei test utili per l'inquadramento diagnostico

Abstract

Get full access to this article

View all access options for this article.

References

Gane

.; Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002; 74(4): 427–37.

Fabrizi

. Treatment of hepatitis C in potential kidney and heart transplant patients Clin Liver Dis 2005; 9(3 HCV & trapianto): 487–503.

Gaiani

. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997; 27(6): 979–85.

Zheng

R.Q.

. Liver fibrosis in chronic viral hepatitis: an ultrasonographic study. World J Gastroenterol 2003; 9(11): 2484–9.

Macias Rodriguez

M.A.

. Ultrasonography in patients with chronic liver disease: its usefulness in the diagnosis of cirrhosis. Rev Esp Enferm Dig 2003; 95(4): 258–64, 251–7.

Aube

. New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol 2004; 16(8): 743–51.

Hung

C.H.

. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J Gastroenterol 2003; 38(2): 153–7.

Colli

. Severe liver fibrosis or cirrhosis: accuracy of US for detection-analysis of 300 cases. Radiology 2003; 227(1): 89–94. Epub 2003 Feb 19.

Bravo

A.A.

, Sheth

S.S.

, Chopra

Liver Biopsy.

N E J Med 2001, 344: 7; 495–500.

10.

Cholongitas

. Transjugular liver biopsy: how good it is for accurate histological interpretation. Gut 2006.

11.

Ishikawa

Comparison of a new aspiration needle device and the Quick-Core biopsy needle for tansjugular liver biopsy.

World Gastroenterol 2006; 12(39): 6339–42.

12.

Perrillo

R.P.

The role of liver biopsy in hepatitis C.

Hepatology 1997; 26(Suppl 1): S57–61.

13.

Dienes

H.P.

. Liver biopsy in hepatitis C. J Hepatol 1999; 31(Suppl 1): 43–6.

14.

Gebo

K.A.

. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002; 36(Suppl 1): S161–72.

15.

Dienstag

J.L.

The role of liver biopsy in chronic hepatitis C.

Hepatology 2002; 36(Suppl 1): S152–60.

16.

Regev

. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2164–8.

17.

Colloredo

. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239–44.

18.

Bedossa

. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449–57.

19.

The METAVIR cooperative group Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C.

Hepatology 1994; 20; 1: 15–20.

20.

Afdhal

N.H.

, Nunes

Evaluation of liver fibrosis: a Concise review.

Am J Gastroenterol 2004: 1160–74.

21.

Myers

R.P.

. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003; 39(2): 222–30.

22.

Poynard

. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004; 50(8): 1344–55. Epub 2004 Jun 10.

23.

Callewaert

. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004; 10(4): 429–34.

24.

Castera

. Prospective comparison of transient elastography, Fibrotest, PRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128(2): 343–50.

25.

Sandrin

. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29(12): 1705–13.

26.

Coco

. Transient elastography, a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Vir Hep (in press).